STERIS (STE)
(Delayed Data from NYSE)
$228.77 USD
+4.48 (2.00%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $228.84 +0.07 (0.03%) 7:58 PM ET
2-Buy of 5 2
C Value C Growth F Momentum D VGM
Brokerage Reports
0 items in cart
STERIS plc [STE]
Reports for Purchase
Showing records 61 - 80 ( 670 total )
Company: STERIS plc
Industry: Medical - Instruments
Company: STERIS plc
Industry: Medical - Instruments
June: Sustaining Momentum into the Summer
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: STERIS plc
Industry: Medical - Instruments
Company: STERIS plc
Industry: Medical - Instruments
Company: STERIS plc
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: STERIS plc
Industry: Medical - Instruments
Company: STERIS plc
Industry: Medical - Instruments
May: Seems Like People Are Going Back to the Doctor
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: STERIS plc
Industry: Medical - Instruments
Company: STERIS plc
Industry: Medical - Instruments
Company: STERIS plc
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: STERIS plc
Industry: Medical - Instruments
Company: STERIS plc
Industry: Medical - Instruments
Company: STERIS plc
Industry: Medical - Instruments
Company: STERIS plc
Industry: Medical - Instruments
Company: STERIS plc
Industry: Medical - Instruments
Company: STERIS plc
Industry: Medical - Instruments
The Monthly Check-Up -Key First Look Data - MedTech
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: STERIS plc
Industry: Medical - Instruments
Company: STERIS plc
Industry: Medical - Instruments
Proposed Updates to EtO Regulations Seem Feasible
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: STERIS plc
Industry: Medical - Instruments
Optimized Entry and Exit Levels for STE 41123
Provider: Stock Traders Daily
Analyst: Research Department
Company: STERIS plc
Industry: Medical - Instruments
Medical Technology: Leaning In on Improving Fundamentals
Provider: KeyBanc Capital Markets
Analyst: Research Department